Point-of-care technologies (POCTs) have grown increasingly prevalent in clinical and at-home settings, offering various rapid diagnostic capabilities. This study presents findings from a nationwide survey of healthcare providers, including physicians, nurses, and allied health professionals, conducted between November 2023 and January 2024, capturing clinician perceptions of POCTs. This survey builds upon previous surveys from 2019 to 2021, and the data reflects a shift in attitudes toward a more neutral standpoint with fewer perceived benefits and concerns.

A total of 159 responses were analyzed. Core priorities, including accuracy, ease of use, and availability, remain consistently valued over the years. However, several perceived benefits, including continuous patient monitoring, diagnostic certainty, and patient management exhibited significant declines in agreement compared to previous years. This decline may be attributed to the increasing real-world experience with POCTs and the associated concerns surrounding inconsistent or inaccurate patient use, particularly in at-home settings. POCTs are now used for broader applications. Despite this, clinician perceptions of POCTs’ abilities to enhance patient-provider communication remained stable. The results suggest a tempered outlook among providers.

Evolving concerns may reflect heightened expectations and greater scrutiny as these technologies become commonplace. Agreement that POCTs may undermine clinical expertise increases, while concerns related to reimbursement and usability declines. Pilot questions related to artificial intelligence and machine learning were introduced; results indicated moderate openness to adopting AI-enhanced POCTs, particularly with tools offering novel clinical insights.

While the results provide valuable insight into an evolving landscape of clinician perceptions, limitations include a smaller sample size than in prior years and missing demographic data from a subset of participants. Future surveys will further integrate AI/ML-related questions while prioritizing broader demographic and geographic reach.

These trends underscore the importance of aligning the needs and expectations of stakeholders to enhance the clinical value of POCTs and improve patient outcomes.

The authors have declared no competing interest.

Yes

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UMass Chan Medical School IRB

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All relevant data are within the manuscript and its Supporting Information files.